ESC Premium Access

Hot Line - EMPEROR-Preserved / EMPEROR-Pooled

Event: ESC Congress 2021 - The Digital Experience
Topic: Chronic Heart Failure
Session type: Hot Line
Date: 27 August 2021
Time: 17:25 - 18:25

Congress Session

Become an ESC member to access this resource

Become a member

Already a member? Sign in

5 presentations in this session

EMPEROR-Preserved: effect of empagliflozin on cardiovascular death and heart failure hospitalisations in patients with heart failure with a preserved ejection fraction, with and without diabetes

Speaker: Professor S. Anker (Berlin, DE)
Thumbnail

EMPEROR-Preserved - Discussant review.

Speaker: Professor F. Ruschitzka (Zurich, CH)
Thumbnail

EMPEROR-Pooled: effect of empagliflozin on serious adverse renal outcomes in chronic heart failure – a prospective alpha-protected, Individual patient-level pooled analysis

Speaker: Doctor M. Packer (Dallas, US)
Thumbnail

EMPEROR-Pooled - Discussant review.

Speaker: Professor R. De Boer (Groningen, NL)
Thumbnail

EMPEROR-Preserved / EMPEROR-Pooled - Panel discussion.

Thumbnail

4 speakers from this session

Professor Stefan Anker

Charite Universitatsmedizin Berlin, Berlin (Germany)
116 presentations
4 followers

Professor Frank Ruschitzka

University Heart Center, Zurich (Switzerland)
82 presentations
4 followers

Doctor Milton Packer

Baylor University Medical Center, Dallas (United States of America)
33 presentations
3 followers

Professor Rudolf De Boer

University Medical Centre Groningen, Groningen (Netherlands (The))
42 presentations
1 follower

Related content

ESC Premium Access

Evolving role of SGLT2i in HFrEF management

3 December 2021

ESC Premium Access

Trials Focus: GUIDE-HF / EMPEROR-Preserved

3 December 2021

ESC Premium Access

Opening session

2 December 2021

This platform is supported by

logo Novo Nordisk